부산대학교 도서관

Keywords: COVID-19; respiratory function; respiratory outcome; respiratory sequelae EN COVID-19 respiratory function respiratory outcome respiratory sequelae 1 5 5 07/27/21 20210801 NES 210801 INTRODUCTION Despite more than 148 million infected people, coronavirus disease 2019 (COVID-19) respiratory intermediate- and long-term survivors' outcome remains largely unknown. Few patients (n = 16, 20%) complained of dyspnoea at 3 months, regardless of COVID-19 severity (19% of patients of the mild-to-moderate group, 20% of the severe group and 20% of the critical disease group, I P i = .98). Approximately 66% of patients with mild-to-moderate and severe disease had normal chest CT scan at 3 months, whereas persistent lung infiltrates - mostly peripheral ground-glass opacities - were observed in 71% of patients with critical disease (Figure 1). These preliminary data support the need to assess respiratory outcomes of the most severe patients after COVID-19, that is patients with critical disease /ARDS. [Extracted from the article]